Literature DB >> 31855619

Association of obesity measures and multimorbidity in Pakistan: findings from the IMPACT study.

M Jawed1, S Inam2, N Shah3, K Shafique4.   

Abstract

OBJECTIVE: Obesity is a major factor leading to multimorbidity. However, the relative importance of obesity measures, including body mass index (BMI), body fat percentage (BF%) and visceral fat (VF), in relation to multimorbidity has not been extensively studied in Asia. Therefore, the objective of this study was to examine the relation of these measures of obesity with multimorbidity in a representative community sample in Pakistan. STUDY
DESIGN: This is a community-based cross-sectional study.
METHODS: This study was conducted among residents of Gulshan town, Karachi, Pakistan. Data on healthy individuals and individuals with chronic conditions were recorded. All self-reported chronic conditions were further assessed by physical examination, medical history of the participants and laboratory findings. Multivariate logistic regression and receiver operating characteristic (ROC) curve analyses of BMI, BF% and VF as predictors of obesity were used to examine the association with multimorbidity.
RESULTS: A total of 1500 participants (738 men and 762 women) were recruited, with a median age of 54.5 years. Multivariate logistic regression showed a significant association of BMI (odds ratio [OR] = 1.28, 95% confidence interval [CI] = 1.00-1.81, P-value 0.049) and BF% (OR = 2.28, 95% CI = 1.50-3.45, P-value <0.001) with multimorbidity. However, the ROC analysis for BMI, BF% and VF showed very similar results, even when the analysis was stratified by gender. In this exploratory analysis, increasing age and female gender were significantly associated with multimorbidity compared with their counterparts.
CONCLUSIONS: Adult populations with high BF% levels carry a higher risk of multimorbidity than those with high BMI scores. In a population with differing metabolic characteristics, BMI might be less precise than direct adiposity measurements. Additional studies are needed to confirm the potential use of measuring the anatomical location and metabolic characteristics of lean and fat mass to identify risk of diseases.
Copyright © 2019 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body fat; Multimorbidity; Obesity; Visceral fat

Mesh:

Year:  2019        PMID: 31855619     DOI: 10.1016/j.puhe.2019.10.017

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  5 in total

1.  The Risk of Multimorbidity Associated with Overweight and Obesity: Data from the Brazilian National Health Survey 2013.

Authors:  Thaynã Ramos Flores; Ana Paula Dos Santos Rodrigues; Rosália Garcia Neves; Sandro Rodrigues Batista; Doralice Severo da Cruz Teixeira; Erika Aparecida da Silveira; Deborah Carvalho Malta; Bruno Pereira Nunes
Journal:  J Obes Metab Syndr       Date:  2021-06-30

2.  Population attributable risk for multimorbidity among adult women in India: Do smoking tobacco, chewing tobacco and consuming alcohol make a difference?

Authors:  Vivek K Mishra; Shobhit Srivastava; Muhammad T; P V Murthy
Journal:  PLoS One       Date:  2021-11-03       Impact factor: 3.240

3.  Gender differences in the association of obesity-related measures with multi-morbidity among older adults in India: evidence from LASI, Wave-1.

Authors:  T Muhammad; Bandita Boro; Manish Kumar; Shobhit Srivastava
Journal:  BMC Geriatr       Date:  2022-03-01       Impact factor: 3.921

4.  A combination of moderate and vigorous physical activities reduces the burden of multimorbidity: findings from Longitudinal Ageing Study in India.

Authors:  Sasmita Behera; Jalandhar Pradhan
Journal:  J Health Popul Nutr       Date:  2022-09-12       Impact factor: 2.966

5.  Multimorbidity of non-communicable diseases in low-income and middle-income countries: a systematic review and meta-analysis.

Authors:  Ogechukwu Augustina Asogwa; Daniel Boateng; Anna Marzà-Florensa; Sanne Peters; Naomi Levitt; Josefien van Olmen; Kerstin Klipstein-Grobusch
Journal:  BMJ Open       Date:  2022-01-21       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.